Sysmex’s PA-100 AST System is redefining the standard of care for diagnosing and treating uncomplicated urinary tract ...

UTI ENERGY, INC. (NASDAQ:PTEN) today reported that for the month of March 2025, the Company had an average of 106 drilling rigs operating in the United States. For the three months ended ...

Blujepa, the first new oral UTI antibiotic in 30 years, offers hope against antibiotic-resistant infections, improving ...

A rare syndrome linked to purple urine reveals surprising insights into bacterial colonisation, metabolism, and risks for ...

We recently published a list of the 12 Best Oil and Gas Dividend Stocks According to Billionaires. In this article, we are ...

A new antibiotic to treat stubborn urinary tract infection (UTI) and a blood-clot-dissolving intravenous treatment for acute ...

If you deal with recurrent UTIs, a new FDA-approved antibiotic called Blujepa could offer another treatment option—especially ...

The FDA has approved Blujepa (gepotidacin) for the treatment of female patients 12 years of age and older weighing at least 40kg with uncomplicated UTI.

Doctors are prescribing antibiotics for tens of thousands of patients with infections, with little or no consideration of ...

Younger people are being increasingly prescribed antibiotics without proper assessment of complication risk, finds a study, ...

Shares of Patterson-UTI Energy, Inc. (NASDAQ:PTEN – Get Free Report) have received a consensus recommendation of “Moderate Buy” from the thirteen research firms that are presently covering the firm, ...